The store will not work correctly when cookies are disabled.
US8969348, {4-[(1-Methyl-1H-indol-3-yl)methyl]-1-oxophthalazin-2(1H)-yl}acetic acid
ID: ALA3691796
PubChem CID: 46175683
Max Phase: Preclinical
Molecular Formula: C20H17N3O3
Molecular Weight: 347.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1cc(Cc2nn(CC(=O)O)c(=O)c3ccccc23)c2ccccc21
Standard InChI: InChI=1S/C20H17N3O3/c1-22-11-13(14-6-4-5-9-18(14)22)10-17-15-7-2-3-8-16(15)20(26)23(21-17)12-19(24)25/h2-9,11H,10,12H2,1H3,(H,24,25)
Standard InChI Key: JUBNTJHSYUBGEB-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
5.9827 2.1504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4982 1.0526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0320 0.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3039 3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3063 4.9494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3421 3.1476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2519 -1.3615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7201 -2.7865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1884 -3.0935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1884 -1.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7201 -0.5504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2519 -0.2434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
10 12 1 0
8 13 1 0
13 14 2 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 6 1 0
20 15 1 0
4 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 2 1 0
26 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 347.37 | Molecular Weight (Monoisotopic): 347.1270 | AlogP: 2.56 | #Rotatable Bonds: 4 |
Polar Surface Area: 77.12 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.47 | CX Basic pKa: ┄ | CX LogP: 2.69 | CX LogD: -0.69 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.62 | Np Likeness Score: -1.04 |
References
1. (2015) Chymase inhibitors, |